Sun Pharma's stock is showing stability, with its six-month beta reflecting this trend. The last traded price was 1720.2, with a market capitalization of 412733.6 and a volume of 2639497. The company's price-to-earnings ratio stands at 39.5, and its earnings per share are 43.55. This liveblog provides real-time updates, fundamental and technical analysis, and expert insights for informed financial decisions.